÷°¡Á¦ | ÀÀ°íÃËÁøÁ¦, gel |
---|---|
ÇØ´ç°Ë»ç | ÀϹÝÈÇÐ °Ë»ç, ¸é¿ªÇ÷û °Ë»ç µî |
°Ëü·® | 5mL |
º¸°ü | ¿ë±â: ½Ç¿Â, Ç÷û ºÐ¸® ÈÄ °Ë»çÇ׸ñ¿¡ µû¶ó ³Ãµ¿, ³ÃÀå, ½Ç¿Â |
Âü°í»çÇ× | ¾à 30ºÐ°£ ½Ç¿Â¿¡¼ ¹æÄ¡ÇÏ¿© ÀÀ°í½ÃŲ ÈÄ Ã¤Ç÷ ÈÄ 2½Ã°£ À̳» ¿ø½ÉºÐ¸® |
ÃֽŠ°Ë»çÇ׸ñ°ú °Ë»çÆÐ³ÎÀ» È®ÀÎÇÏ½Ç ¼ö ÀÖ½À´Ï´Ù.
°ËüÁ¾·ù |
![]() SST (Serum separating tube) |
|
---|---|---|
°Ëü·® | 1mL | |
°Ëüº¸°ü | ³ÃÀå | |
°Ëü¾ÈÁ¤¼º | ½Ç¿Â: 1ÀÏ ³ÃÀå: 7ÀÏ |
|
Âü°íÄ¡ | [MFIr] Negative ¡Â 2.02 2.02 < Borderline or low positive ¡Â 2.61 2.61 < Positive *MFIr: Mean fluorescence intensity of FITC channel |
|
ÀÓ»óÀûÀÇÀÇ | MOG-EM (myelin oligodendrocyte glycoprotein encephalomyelitis)Àº ÁßÃ߽Űæ°è Å»¼öÃÊ ÁúȯÀÇ Çϳª·Î ±Þ¼º½Ã½Å°æ¿°, ô¼ö¿°, ³ú°£ ³ú¿° µîÀÇ Áõ»óÀÌ ¹ß»ýÇÏ´Â ÁúȯÀÌ´Ù. ½Ã½Å¿°, ô¼ö¿° ȤÀº ±âŸ ½Ã½Å°æÃ´¼ö¿° ¹üÁÖ ÁúȯÀÇ ÀÓ»ó ¾ç»óÀ» º¸À̴ ȯÀÚÀÇ ÀϺο¡¼ AQP4 Ab´Â À½¼ºÀ̳ª MOG Ab°¡ ¹ß°ßµÉ ¼ö ÀÖÀ¸¹Ç·Î MOG Ab¿Í AQP4 Ab¸¦ º´ÇàÇÏ¿© Áø´Ü¿¡ µµ¿òÀ» ÁÙ ¼ö ÀÖ´Ù. |
|
ÁÖÀÇ»çÇ× | ||
Çʼö¼·ù | ||
ÃֽŰø¹® |